ZNF398
gene geneOn this page
Also known as p71-ZER6p52-ZER6ZER6KIAA1339P51P71
Summary
ZNF398 (zinc finger protein 398, HGNC:18373) is a protein-coding gene on chromosome 7q36.1, encoding Zinc finger protein 398 (Q8TD17). Functions as a transcriptional activator.
This gene encodes a member of the Kruppel family of C2H2-type zinc-finger transcription factor proteins. The encoded protein acts as a transcriptional activator. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described, but their full length sequence has not been determined.
Source: NCBI Gene 57541 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 93 total
- MANE Select transcript:
NM_170686
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18373 |
| Approved symbol | ZNF398 |
| Name | zinc finger protein 398 |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | p71-ZER6, p52-ZER6, ZER6, KIAA1339, P51, P71 |
| Ensembl gene | ENSG00000197024 |
| Ensembl biotype | protein_coding |
| OMIM | 618593 |
| Entrez | 57541 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000426851, ENST00000475153, ENST00000483892, ENST00000485111, ENST00000491174, ENST00000957024
RefSeq mRNA: 2 — MANE Select: NM_170686
NM_020781, NM_170686
CCDS: CCDS47739, CCDS5894
Canonical transcript exons
ENST00000475153 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001172268 | 149166817 | 149166930 |
| ENSE00001361399 | 149176468 | 149176581 |
| ENSE00001753514 | 149147453 | 149147766 |
| ENSE00001896077 | 149178648 | 149183042 |
| ENSE00003558494 | 149166158 | 149166284 |
| ENSE00003674393 | 149153945 | 149154340 |
Expression profiles
Bgee: expression breadth ubiquitous, 246 present calls, max score 95.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.1787 / max 371.8702, expressed in 1803 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 81880 | 17.1900 | 1800 |
| 81881 | 1.1788 | 602 |
| 81876 | 0.8934 | 528 |
| 81878 | 0.5642 | 292 |
| 81879 | 0.3523 | 165 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 95.46 | gold quality |
| endothelial cell | CL:0000115 | 90.66 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 88.78 | gold quality |
| amniotic fluid | UBERON:0000173 | 88.46 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 87.54 | gold quality |
| cerebellar vermis | UBERON:0004720 | 87.00 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 86.75 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 86.56 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 86.44 | silver quality |
| skin of hip | UBERON:0001554 | 84.84 | gold quality |
| ileal mucosa | UBERON:0000331 | 84.67 | gold quality |
| visceral pleura | UBERON:0002401 | 84.57 | gold quality |
| gingival epithelium | UBERON:0001949 | 84.43 | gold quality |
| upper arm skin | UBERON:0004263 | 84.35 | gold quality |
| tibia | UBERON:0000979 | 84.22 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 84.17 | gold quality |
| cortical plate | UBERON:0005343 | 84.08 | gold quality |
| sperm | CL:0000019 | 83.50 | gold quality |
| gingiva | UBERON:0001828 | 83.10 | gold quality |
| tibialis anterior | UBERON:0001385 | 82.91 | silver quality |
| parietal pleura | UBERON:0002400 | 82.51 | gold quality |
| primary visual cortex | UBERON:0002436 | 81.86 | gold quality |
| blood | UBERON:0000178 | 81.71 | gold quality |
| bronchial epithelial cell | CL:0002328 | 81.61 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 81.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.24 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.02 | gold quality |
| bronchus | UBERON:0002185 | 80.96 | gold quality |
| upper leg skin | UBERON:0004262 | 80.91 | gold quality |
| postcentral gyrus | UBERON:0002581 | 80.84 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124858 | no | 193.97 |
| E-ANND-3 | no | 3.68 |
| E-MTAB-5061 | no | 3.48 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
3 targets.
| Target | Regulation |
|---|---|
| CDKN2A | |
| ZNF354C | |
| ZNF398 |
Upstream regulators (CollecTRI, top): ESR1, NFKB2, STAT1, ZNF398
miRNA regulators (miRDB)
101 targeting ZNF398, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-219A-5P | 99.91 | 73.36 | 735 |
| HSA-MIR-4782-3P | 99.88 | 73.31 | 735 |
| HSA-MIR-6766-3P | 99.88 | 73.38 | 732 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-5197-5P | 99.64 | 69.08 | 1494 |
| HSA-MIR-1251-3P | 99.64 | 67.21 | 1408 |
| HSA-MIR-7150 | 99.62 | 66.80 | 1322 |
Literature-anchored findings (GeneRIF, showing 1)
- The transcriptional regulator ZNF398 mediates pluripotency and epithelial character downstream of TGF-beta in human PSCs. (PMID:32398665)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp398 | ENSMUSG00000062519 |
| rattus_norvegicus | Zfp398 | ENSRNOG00000006703 |
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391)
Protein
Protein identifiers
Zinc finger protein 398 — Q8TD17 (reviewed: Q8TD17)
Alternative names: Zinc finger DNA-binding protein p52/p71
All UniProt accessions (3): Q8TD17, A0A090N7S8, A0A090N8F2
UniProt curated annotations — full annotation on UniProt →
Function. Functions as a transcriptional activator.
Subcellular location. Nucleus.
Induction. By estrogen receptor alpha.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TD17-1 | 1, p71 | yes |
| Q8TD17-2 | 2, p52 |
RefSeq proteins (2): NP_065832, NP_733787* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003655 | aKRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13913
UniProt features (19 total): zinc finger region 9, region of interest 3, sequence variant 2, chain 1, domain 1, compositionally biased region 1, cross-link 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TD17-F1 | 61.20 | 0.19 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 265
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 135 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, AP4_Q6, CAGCTG_AP4_Q5, GROSS_HYPOXIA_VIA_ELK3_DN, TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN, OSMAN_BLADDER_CANCER_DN, HEB_Q6, BENPORATH_ES_1, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, LIU_PROSTATE_CANCER_DN, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ATF6_TARGET_GENES
GO Biological Process (3): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), positive regulation of DNA-templated transcription (GO:0045893)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 2 |
| regulation of DNA-templated transcription | 2 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription by RNA polymerase II | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
987 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF398 | DDX17 | Q92841 | 807 |
| ZNF398 | ICA1 | P78506 | 611 |
| ZNF398 | NKTR | P30414 | 511 |
| ZNF398 | POLDIP3 | Q9BY77 | 507 |
| ZNF398 | MDM2 | Q00987 | 464 |
| ZNF398 | MYL2 | P10916 | 461 |
| ZNF398 | STRBP | Q96SI9 | 450 |
| ZNF398 | AP3M2 | P53677 | 445 |
| ZNF398 | YPEL3 | P61236 | 427 |
| ZNF398 | ACOT13 | Q9NPJ3 | 421 |
| ZNF398 | PCMT1 | P22061 | 418 |
| ZNF398 | UGGT2 | Q9NYU1 | 414 |
| ZNF398 | TMBIM6 | P55061 | 404 |
| ZNF398 | EMG1 | Q92979 | 404 |
| ZNF398 | ZNF534 | Q76KX8 | 402 |
IntAct
91 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF398 | ELMO1 | psi-mi:“MI:0915”(physical association) | 0.800 |
| ELMO1 | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.800 |
| ZNF398 | MFAP1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| MFAP1 | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF783 | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.740 |
| ZNF398 | ZNF783 | psi-mi:“MI:0915”(physical association) | 0.740 |
| ZNF398 | CLK2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF398 | MAGOHB | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF398 | CIB3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MAGOHB | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CIB3 | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CLK2 | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF398 | ZNF282 | psi-mi:“MI:0914”(association) | 0.710 |
| ZNF282 | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.710 |
| GPATCH2L | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.670 |
| AIRIM | ZNF398 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF398 | GPATCH2L | psi-mi:“MI:0915”(physical association) | 0.670 |
BioGRID (62): ZNF398 (Two-hybrid), ZNF398 (Two-hybrid), ZNF398 (Two-hybrid), ZNF398 (Two-hybrid), ZNF398 (Two-hybrid), ZNF398 (Two-hybrid), ZNF398 (Two-hybrid), PLEKHF2 (Two-hybrid), CIB3 (Two-hybrid), LOC155060 (Two-hybrid), ZNF398 (Affinity Capture-MS), ZNF398 (Two-hybrid), ZNF282 (Affinity Capture-MS), ZNF398 (Affinity Capture-MS), ZNF398 (Affinity Capture-MS)
ESM2 similar proteins: A1A5P9, A2AVR2, A6QPT6, B2KFW1, O14978, P17029, P17040, P17098, P25233, P70503, Q13342, Q14D33, Q3SYK4, Q3V3Q4, Q4KLI1, Q4R8H9, Q4V8E9, Q5PPP4, Q5R670, Q5R7U0, Q5VWK0, Q61066, Q63HK3, Q68CQ1, Q6PCZ4, Q7TS72, Q80ZG2, Q8BGS3, Q8CF60, Q8IWY8, Q8N660, Q8NDZ0, Q8TD17, Q921B4, Q923B3, Q96D09, Q96GC6, Q96JL9, Q96M43, Q99608
Diamond homologs: A0A163UT06, A2AGX3, A6QPM3, B1AUS7, E9Q3T6, O60224, O75626, P0C6Y7, P52736, Q13029, Q16384, Q16385, Q3UZD5, Q5R5M1, Q60636, Q63755, Q6P2A1, Q6PGE4, Q7RTT6, Q80V63, Q86UQ0, Q8BZ97, Q8TD17, Q96EQ9, Q99909, Q9GZV8, Q9NQV5, Q9NQV7, Q9NQV8, Q9NQW5, Q9NQX0, Q9QZP2, Q9UDV7, Q9UKN5, Q9ULD5, A2A761, A6NFI3, A6NK75, A6NM28, A6NP11
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
93 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 86 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1057 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:149153944:GAC:G | acceptor_gain | 1.0000 |
| 7:149154326:G:GT | donor_gain | 1.0000 |
| 7:149166283:GG:G | donor_gain | 1.0000 |
| 7:149166284:GG:G | donor_gain | 1.0000 |
| 7:149166290:GC:G | donor_gain | 1.0000 |
| 7:149166291:C:G | donor_gain | 1.0000 |
| 7:149166312:G:GT | donor_gain | 1.0000 |
| 7:149166812:CCTAG:C | acceptor_loss | 1.0000 |
| 7:149166816:G:GT | acceptor_loss | 1.0000 |
| 7:149166816:GATT:G | acceptor_gain | 1.0000 |
| 7:149166927:GAAG:G | donor_gain | 1.0000 |
| 7:149166930:GGTA:G | donor_loss | 1.0000 |
| 7:149166931:G:C | donor_loss | 1.0000 |
| 7:149166931:G:GG | donor_gain | 1.0000 |
| 7:149176459:A:AG | acceptor_gain | 1.0000 |
| 7:149176460:C:G | acceptor_gain | 1.0000 |
| 7:149176461:A:AG | acceptor_gain | 1.0000 |
| 7:149176462:A:G | acceptor_gain | 1.0000 |
| 7:149176578:GCTG:G | donor_gain | 1.0000 |
| 7:149176579:CTGGT:C | donor_loss | 1.0000 |
| 7:149176580:TG:T | donor_gain | 1.0000 |
| 7:149176580:TGG:T | donor_loss | 1.0000 |
| 7:149176581:GG:G | donor_gain | 1.0000 |
| 7:149176581:GGTG:G | donor_loss | 1.0000 |
| 7:149176582:G:A | donor_loss | 1.0000 |
| 7:149176582:G:GG | donor_gain | 1.0000 |
| 7:149176583:TGAG:T | donor_loss | 1.0000 |
| 7:149176584:G:GT | donor_loss | 1.0000 |
| 7:149147591:GCCGC:G | donor_gain | 0.9900 |
| 7:149153927:T:G | acceptor_gain | 0.9900 |
AlphaMissense
4216 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:149179430:T:C | F520L | 1.000 |
| 7:149179431:T:C | F520S | 1.000 |
| 7:149179432:C:A | F520L | 1.000 |
| 7:149179432:C:G | F520L | 1.000 |
| 7:149179457:C:G | H529D | 1.000 |
| 7:149179514:T:C | F548L | 1.000 |
| 7:149179515:T:C | F548S | 1.000 |
| 7:149179516:C:A | F548L | 1.000 |
| 7:149179516:C:G | F548L | 1.000 |
| 7:149179533:T:C | L554P | 1.000 |
| 7:149179598:T:C | F576L | 1.000 |
| 7:149179600:C:A | F576L | 1.000 |
| 7:149179600:C:G | F576L | 1.000 |
| 7:149179157:T:C | C429R | 0.999 |
| 7:149179178:T:C | F436L | 0.999 |
| 7:149179179:T:C | F436S | 0.999 |
| 7:149179180:T:A | F436L | 0.999 |
| 7:149179180:T:G | F436L | 0.999 |
| 7:149179205:C:G | H445D | 0.999 |
| 7:149179262:T:C | F464L | 0.999 |
| 7:149179264:C:A | F464L | 0.999 |
| 7:149179264:C:G | F464L | 0.999 |
| 7:149179289:C:G | H473D | 0.999 |
| 7:149179325:T:C | C485R | 0.999 |
| 7:149179334:T:A | C488S | 0.999 |
| 7:149179335:G:C | C488S | 0.999 |
| 7:149179346:T:C | F492L | 0.999 |
| 7:149179347:T:C | F492S | 0.999 |
| 7:149179348:C:A | F492L | 0.999 |
| 7:149179348:C:G | F492L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000032075 (7:149157004 C>G), RS1000048169 (7:149165035 A>C,G), RS1000049038 (7:149125009 A>C), RS1000103072 (7:149164699 G>A), RS1000160732 (7:149151358 G>A,T), RS1000232128 (7:149159577 G>A,T), RS1000236509 (7:149151090 G>A), RS1000316359 (7:149130561 T>G), RS1000362548 (7:149145138 T>A), RS1000398837 (7:149125310 G>A), RS1000408586 (7:149157250 C>A,T), RS1000481840 (7:149136691 C>G,T), RS1000608861 (7:149169360 C>T), RS1000647061 (7:149146902 A>G), RS1000656636 (7:149129127 A>G)
Disease associations
OMIM: gene MIM:618593 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004600_38 | Eosinophil percentage of white cells | 7.000000e-41 |
| GCST004606_149 | Eosinophil count | 2.000000e-32 |
| GCST004617_14 | Eosinophil percentage of granulocytes | 1.000000e-40 |
| GCST004623_113 | Neutrophil percentage of granulocytes | 1.000000e-38 |
| GCST004624_107 | Sum eosinophil basophil counts | 2.000000e-28 |
| GCST90002399_187 | Neutrophil percentage of white cells | 6.000000e-16 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007991 | eosinophil percentage of leukocytes |
| EFO:0004842 | eosinophil count |
| EFO:0007996 | eosinophil percentage of granulocytes |
| EFO:0007994 | neutrophil percentage of granulocytes |
| EFO:0005090 | basophil count |
| EFO:0007990 | neutrophil percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, increases methylation | 3 |
| sodium arsenite | increases expression, increases abundance | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Camptothecin | increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Indomethacin | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 1 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D8YF | Ubigene HCT 116 ZNF398 KO | Cancer cell line | Male |
| CVCL_XW41 | HEK293 eGFP-ZNF398 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.